🇺🇸 FDA
Patent

US 6413523

Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use

expired A61KA61K2039/55544A61K39/39

Quick answer

US patent 6413523 (Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use) held by United States of America as represented by the Secretary of the Air Force expires Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jul 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/55544, A61K39/39